DACH
Rockaway plans third closing for Rockaway Ventures Fund this autumn
EUR 100m fundraise marks one of the first vehicles for which the Czech VC firm has invited external investors on board
DPE to exit VTU Group in sale to Altor Capital
New sponsor will hold a majority stake in the Austrian engineering group with management reinvesting
Ardian preps Imes-icore for sale; sellside pitches ongoing
Healthcare tech company could hit the German auction pipeline later this year
Gyrus reaps 8.6x money from partial dss+ exit to Inflexion
Majority investment in Switzerland-headquartered management consultancy marks Inflexion Buyout Fund VI’s fifth deal
Ocean 14 Capital plans June final close for debut 'blue economy' fund
Article 9 growth fund is expected to exceed its EUR 150m target and will back 20-25 businesses
EQT faces selldown dilemma as realisation pressure dawns
Swedish GP still holds large stakes in Azelis, Suse more than 18 months after listings; could look to selldown in H2 2023
Argos Wityu acquires Norline in sixth deal from Mid-Market VIII
Sponsor’s EUR 450m Mid-Market VIII fund held a final close in 2022 and is almost 50% deployed
Triton on the road for Fund VI with EUR 5.5bn target
Latest flagship fund aims to raise slightly more than its EUR 5bn, 2018-vintage predecessor
Constructive approach: PEs turn to bolt-ons amid exits and debt crunch
Buy-and-build strategies to take centre stage for sponsors faced with longer holding periods and tough market for platform investments
Unquote Private Equity Podcast: Après IPEM and the road ahead
Harriet Matthews and Min Ho share what they gleaned from the conference in Cannes and what this means for investment and fundraising outlooks
Planet A raises EUR 160m for debut greentech fund
German VC will back scaleable hardware and software startups, giving science team "veto power" in investment decisions
Carlyle private equity fundraising slumps behind peers
Sponsor remains on the road for its eighth flagship fund amid turmoil at CEO-level, with fundraising lagging behind peers KKR and EQT
Accession Capital Partners aims for autumn 2023 final close for Fund V
Sponsor has held a EUR 150m first close for its latest fund and will back Central European businesses with flexible capital
McDermott adds to German PE team with Noerr and Latham duo
Noerr’s Holger Ebersberger and Latham & Watkins’ Hanno Witt to join the firm’s Munich office
Oakley raises EUR 2.85bn for fifth flagship fund
More than twice the size of its 2019 predecessor, the vehicle will allow for larger equity tickets, more investments and bolt-ons
Integra Partners heads for year-end close for EUR 250m second fund
Vehicle is open to retail investors with tickets of EUR 500,000-plus and will make fund and co-investments
Capiton moves two assets to continuation vehicle; Fund V largely unrealised
Eurazeo and Unigestion among LPs in new fund for industrial tech businesses Raith and AEMtec
GP Profile: Armen eyes “new frontier” for GP stakes in Europe
France-headquartered GP stakes investor is seeking to support sponsors as they become multi-strategy managers, co-founder Dominique Gaillard tells Unquote
Women in VC: Revaia’s Albizzati on founding a female-led firm and navigating valuations in 2023
Co-founder Alice Albizzati outlines the growth equity firm's priorities as it heads for the final close of its EUR 500m Fund II
SoftwareONE on PE watchlist amid take-private optimism
Switzerland-listed cloud technology group has been eyed by several buyout houses in recent months
IPEM 2023: GPs battle fundraising blues on the Côte d'Azur
Sponsors remain broadly optimistic despite fundraise bottlenecks and a growing number of LPs faced with tough choices on manager selection
Main Capital exits Onventis in SBO to Keensight
Exit from Main Fund V comes three years after the GP acquired the Germany-based procurement technology company
The Bolt-Ons Digest – 26 January 2023
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons